Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Aug;44(2):189–200. doi: 10.1038/bjc.1981.170

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

A P Wilson, F E Neal
PMCID: PMC2010732  PMID: 6791675

Abstract

The in vitro chemosensitivity of primary monolayer cultures of human ovarian tumours to a wide range of chemotherapeutic agents has been determined using 3H-leucine incorporation as an index of cytotoxicity. Of 67 specimens received, 35 have been successfully cultured and tested for chemosensitivity. Drugs tested included alkylating agents, antibiotics, antimitotics, antimetabolites and progestogens. The overall incidence of efficacy of the drugs corresponded with the incidence which might be expected from data on the clinical response rates produced by the various drugs. Cultures from the tumour cells of treated patients generally showed greater resistance than tumours of untreated patients. Correlation between in vitro results and in vivo response was positive in all 8 patients receiving first-line chemotherapy and in 57% (4/7) patients receiving second-line chemotherapy.

Full text

PDF
189

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberts D. S., Chang S. Y., Chen H. S., Larcom B. J., Jones S. E. Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report. Cancer Treat Rev. 1979 Jun;6 (Suppl):9–17. doi: 10.1016/s0305-7372(79)80005-5. [DOI] [PubMed] [Google Scholar]
  2. Alberts D. S., Chen H. S., Mayersohn M., Perrier D., Moon T. E., Gross J. F. Bleomycin pharmacokinetics in man. II. Intracavitary administration. Cancer Chemother Pharmacol. 1979;2(2):127–132. doi: 10.1007/BF00254085. [DOI] [PubMed] [Google Scholar]
  3. Alberts D. S., Samon S. E., Chen H. S., Surwit E. A., Soehnlen B., Young L., Moon T. E. In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet. 1980 Aug 16;2(8190):340–342. doi: 10.1016/s0140-6736(80)90340-2. [DOI] [PubMed] [Google Scholar]
  4. Barlow J. J., Piver M. S. Single agent vs combination chemotherapy in the treatment of ovarian cancer. Obstet Gynecol. 1977 May;49(5):609–611. [PubMed] [Google Scholar]
  5. Berry R. J., Laing A. H., Wells J. Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy. Br J Cancer. 1975 Feb;31(2):218–227. doi: 10.1038/bjc.1975.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bischoff K. B., Dedrick R. L., Zaharko D. S., Longstreth J. A. Methotrexate pharmacokinetics. J Pharm Sci. 1971 Aug;60(8):1128–1133. doi: 10.1002/jps.2600600803. [DOI] [PubMed] [Google Scholar]
  7. Coffey J. J., White C. A., Lesk A. B., Rogers W. I., Serpick A. A. Effect of allopurinol on the pharmacokinetics of 6-mercaptopurine (NSC 755) in cancer patients. Cancer Res. 1972 Jun;32(6):1283–1289. [PubMed] [Google Scholar]
  8. Connors T. A., Cox P. J., Farmer P. B., Foster A. B., Jarman M. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem Pharmacol. 1974 Jan 1;23(1):115–129. doi: 10.1016/0006-2952(74)90318-9. [DOI] [PubMed] [Google Scholar]
  9. Dedrick R. L., Forrester D. D., Ho D. H. In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine. Biochem Pharmacol. 1972 Jan;21(1):1–16. doi: 10.1016/0006-2952(72)90245-6. [DOI] [PubMed] [Google Scholar]
  10. Dendy P. P., Bozman G., Wheeler T. K. In-vitro screening test for human malignant tumours before chemotherapy. Lancet. 1970 Jul 11;1(7663):68–72. doi: 10.1016/s0140-6736(70)92640-1. [DOI] [PubMed] [Google Scholar]
  11. Finj C., Sadée W. Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography. Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):279–286. [PubMed] [Google Scholar]
  12. Freshney R. I., Paul J., Kane I. M. Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment. Br J Cancer. 1975 Jan;31(1):89–99. doi: 10.1038/bjc.1975.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harris P. A., Gross J. F. Preliminary pharmacokinetic model for adriamycin (NSC-123127). Cancer Chemother Rep. 1975 Jul-Aug;59(4):819–825. [PubMed] [Google Scholar]
  14. Holmes H. L., Little J. M. Tissue-culture microtest for predicting response of human cancer to chemotherapy. Lancet. 1974 Oct 26;2(7887):985–987. doi: 10.1016/s0140-6736(74)92075-3. [DOI] [PubMed] [Google Scholar]
  15. Ioachim H. L., Sabbath M., Andersson B., Barber H. R. Tissue cultures of ovarian carcinomas. Lab Invest. 1974 Oct;31(4):381–390. [PubMed] [Google Scholar]
  16. Lieberman A., LeBrun Y., Glass P., Goodgold A., Lux W., Wise A., Ransohoff J. Use of high dose corticosteroids in patients with inoperable brain tumours. J Neurol Neurosurg Psychiatry. 1977 Jul;40(7):678–682. doi: 10.1136/jnnp.40.7.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Limburg H., Heckmann U. Chemotherapy in the treatment of advanced pelvic malignant disease with special reference to ovarian cancer. J Obstet Gynaecol Br Commonw. 1968 Dec;75(12):1246–1255. doi: 10.1111/j.1471-0528.1968.tb02931.x. [DOI] [PubMed] [Google Scholar]
  18. Malkasian G. D., Jr, Decker D. G., Jorgensen E. O., Edmonson J. H. Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma. Cancer Treat Rep. 1977 Aug;61(5):913–914. [PubMed] [Google Scholar]
  19. Owellen R. J., Hartke C. A., Hains F. O. Pharmacokinetics and metabolism of vinblastine in humans. Cancer Res. 1977 Aug;37(8 Pt 1):2597–2602. [PubMed] [Google Scholar]
  20. Owellen R. J., Root M. A., Hains F. O. Pharmacokinetics of vindesine and vincristine in humans. Cancer Res. 1977 Aug;37(8 Pt 1):2603–2607. [PubMed] [Google Scholar]
  21. Patton T. F., Himmelstein K. J., Belt R., Bannister S. J., Sternson L. A., Repta A. J. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep. 1978 Sep;62(9):1359–1362. [PubMed] [Google Scholar]
  22. Rutty C. J., Connors T. A. In vitro studies with hexamethylmelamine. Biochem Pharmacol. 1977 Dec 15;26(24):2385–2391. doi: 10.1016/0006-2952(77)90446-4. [DOI] [PubMed] [Google Scholar]
  23. Rutty C. J., Connors T. A., Nguyen-Hoang-Nam, Do-Cao-Thang, Hoellinger H. In vivo studies with hexamethylmelamine. Eur J Cancer. 1978 Jun;14(6):713–720. doi: 10.1016/0014-2964(78)90308-0. [DOI] [PubMed] [Google Scholar]
  24. Schabel F. M., Jr, Trader M. W., Laster W. R., Jr, Wheeler G. P., Witt M. H. Patterns of resistance and therapeutic synergism among alkylating agents. Antibiot Chemother (1971) 1978;23:200–215. doi: 10.1159/000401484. [DOI] [PubMed] [Google Scholar]
  25. Tattersall M. H., Sodergren J. E., Dengupta S. K., Trites D. H., Modest E. J., Frei E., 3rd Pharmacokinetics of actinoymcin D in patients with malignant melanoma. Clin Pharmacol Ther. 1975 Jun;17(6):701–708. doi: 10.1002/cpt1975176701. [DOI] [PubMed] [Google Scholar]
  26. WRIGHT J. C., COBB J. P., GUMPORT S. L., GOLOMB F. M., SAFADI D. Investigation of the relation between clinical and tissue-culture response to chemotherapeutic agents on human cancer. N Engl J Med. 1957 Dec 19;257(25):1207–1211. doi: 10.1056/NEJM195712192572502. [DOI] [PubMed] [Google Scholar]
  27. Wheeler T. K., Dendy P. P., Dawson A. Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease. Oncology. 1974;30(5):362–376. doi: 10.1159/000224977. [DOI] [PubMed] [Google Scholar]
  28. Whiting B., Miller S. H., Caddy B. A procedure for monitoring cyclophosphamide and isophosphamide in biological samples. Br J Clin Pharmacol. 1978 Oct;6(4):373–376. doi: 10.1111/j.1365-2125.1978.tb00869.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES